You just read:

Seqirus Presents New Clinical Data that Reinforce the Ability of MF59® Adjuvanted Seasonal and Pandemic Influenza Vaccines to Increase Immune Response

News provided by

Seqirus

Aug 30, 2019, 08:30 ET